1 Result: Aclarion
Agreements Boost Aclarion and HeartBeam, Analysts' Eyes on Kenvue
May 30th, 2023
Aclarion, Inc. (Nasdaq: ACON) has entered into a commercial agreement with the prestigious London Clinic, a renowned independent hospital in London's medical district. This collaboration allows Aclarion to leverage the Clinic's advanced facilities an. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login